drugset / Trial / NCT03417401

Surgical Stabilizer Assisted RVC With rtPA for CRVO

NCT03417401

NaSingle-groupOpen-labelTreatment

Summary

This phase Ib study investigates the safety and efficacy of performing a retinal vein cannulation with recombinant tissue Plasminogen Activator infusion into a retinal vein with the help of an updated dedicated surgical stabiliser for the treatment of central retinal vein occlusion.

Timeline

Start
2018-10-16
Primary completion
2021-12-10
Completion
2021-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic 1 mg Intravenous